Cargando…
Metformin for the management of tuberous sclerosis: What does the evidence tell us?
Autores principales: | Srinivasan, Anirudh, Naga Shashi Kiran, Beti, Koduvath, Abdulla, Pal, Auroprakash, Suresh, Ananthu, Kannan, Amudhan, Ravichandran, Mirunalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600156/ https://www.ncbi.nlm.nih.gov/pubmed/34803555 http://dx.doi.org/10.17179/excli2021-4213 |
Ejemplares similares
-
A rare case of extensive cutaneous spider angioma in Zieve’s syndrome: A case report and review of literature
por: Sivanandam, Lokesh Koumar, et al.
Publicado: (2022) -
Optimal timing of antimicrobial prophylaxis before surgery: a review of recent evidence
por: Sathoo, Saarat, et al.
Publicado: (2021) -
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
por: Sáenz-Cuesta, Matías, et al.
Publicado: (2014) -
Is Single-Dose Antimicrobial Prophylaxis Sufficient to Control Infections in Gastrointestinal Oncological Surgeries?
por: Kannan, Amudhan, et al.
Publicado: (2021) -
Retinal Astrocytic Hamartoma in Tuberous Sclerosis
por: Mishra, Chitaranjan, et al.
Publicado: (2019)